OCTANT BIO
Octant Bio is a developer of synthetic technology used to improve health and treat disease. Its technology uses synthetic biology, genome engineering, next-generation sequencing, and computational tools to simultaneously measure the activity of thousands of receptor pathways in human cells that enable scientists to apply machine learning methods to engineer small molecules that interact with multiple receptors and unlock a new potential to treat complex diseases.
OCTANT BIO
Industry:
Biotechnology Life Science
Founded:
2017-01-01
Address:
Los Angeles, California, United States
Country:
United States
Website Url:
http://www.octant.bio
Total Employee:
11+
Status:
Active
Total Funding:
115 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Domain Not Resolving Amazon Google Apps For Business JsDelivr
Similar Organizations
hC Bioscience
hC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.
Current Advisors List
Board_observer
2022-04-01
Board_member
2022-04-01
Board_observer
2022-04-01
Current Employees Featured
Ling Wong Investor @ Octant Bio
Investor
2019-01-01
Sri Kosuri founder and CEO @ Octant Bio
founder and CEO
Ramsey Homsany Co-Founder & President @ Octant Bio
Co-Founder & President
2017-06-01
Founder
Investors List
What If Ventures
What If Ventures investment in Series B - Octant Bio
Allen & Company
Allen & Company investment in Series B - Octant Bio
Bristol Myers Squibb
Bristol Myers Squibb investment in Series B - Octant Bio
Andreessen Horowitz
Andreessen Horowitz investment in Series B - Octant Bio
Fifty Years
Fifty Years investment in Series B - Octant Bio
Catalio Capital Management
Catalio Capital Management investment in Series B - Octant Bio
Bioverge
Bioverge investment in Series B - Octant Bio
Flucas Ventures
Flucas Ventures investment in Series B - Octant Bio
Andreessen Horowitz
Andreessen Horowitz investment in Series A - Octant Bio
Allen & Company
Allen & Company investment in Series A - Octant Bio
Official Site Inspections
http://www.octant.bio Semrush global rank: 2.15 M Semrush visits lastest month: 9.32 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Octant Bio"
Octant
The Octant platform is enabled, processed, and accelerated by our advanced AI/ML pipelines and tools. Our proprietary chemical biology datasets generate unique insights from millions of …See details»
Octant Bio - Crunchbase Company Profile & Funding
Octant Bio is a developer of synthetic technology used to improve health and treat disease. Its technology uses synthetic biology, genome engineering, next-generation sequencing, and …See details»
Octant - LinkedIn
Octant is a well-backed team of experienced technologists and entrepreneurs navigating the complexity of biology and chemistry to develop next generation small molecules.See details»
Octant Bio - Contacts, Employees, Board Members, Advisors
Organization. Octant Bio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. Number of Board …See details»
Octant Bio | World Economic Forum
Octant Bio is a developer of synthetic technology used to improve health and treat disease. Its technology uses synthetic biology, genome engineering, next-generation sequencing, and computational tools to simultaneously measure …See details»
New Universe - octant.bio
Octant engineers biology and chemistry at massive scales to modulate the function itself, targeting complex cellular mechanisms that drive disease. We've focused these efforts …See details»
Octant Bio - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised ... May 21, 2020: Series A - Octant Bio . 7: …See details»
Octant - Company Profile - Tracxn
Feb 1, 2025 Octant - Provider of human cell interaction platform for drug discovery. Raised a total funding of $115M over 2 rounds from 14 investors. ... Email ID: *****@octant.bio; Key …See details»
Synthetic biology firm Octant closes $80M funding, …
Apr 21, 2022 Data-driven therapeutics company Octant Bio is exploring new frontiers of drug development with $80 million in-pocket and a freshly signed Big Pharma partnership.. Octant—a historical instrument ...See details»
Octant Bio Company Profile - Office Locations, Competitors ... - Craft
Octant Bio has 5 employees at their 1 location and $35 m in total funding,. See insights on Octant Bio including office locations, competitors, revenue, financials, executives, subsidiaries and …See details»
Octant Bio 2025 Company Profile: Valuation, Funding & Investors
Octant Bio General Information Description. Developer of synthetic technology designed to improve health and treat disease. The company's platform uses synthetic biology, genome …See details»
Who Owns Octant Bio – CANVAS, SWOT, PESTEL & BCG Matrix …
Dec 19, 2024 At Octant Bio, ownership is not just about who holds the majority stake in the company, but also about the vision and values that drive the organization forward. The …See details»
The Insanely Fast Wave Of Octant Bio - Ulu Ventures
Jul 17, 2020 Why a hot startup open-sourced their most in-demand technology during COVID19. Octant Bio, an Ulu portfolio company, uses synthetic biology to advance computational drug …See details»
Mission, Vision & Core Values of Octant Bio
Dec 19, 2024 [cbm_blg_rlnkng]Octant Bio is a company driven by a bold mission, unwavering vision, and core values that set the foundation for everything we do. ... Collaboration: We …See details»
Octant Bio - Crunchbase
Octant Bio, ONI, Kytopen, Abogen Biosciences, and Cerevance are all involved in the biotechnology and life sciences sector. ONI and Kytopen focus on advanced microscopy and …See details»
Octant Bio: A Platform for Drug Discovery in Complex Diseases
Jul 8, 2020 The Octant Bio platform today In the past decade, two complementary fields have emerged from academic labs to revolutionize the life sciences industry: synthetic biology and …See details»
Octant Blog: Octant's Multiplexing Superpowers
To put this in perspective, let's say you want to test 100 cellular receptors against 100 different drugging conditions in triplicate. 100 receptors x 100 conditions x 3 repeats would require …See details»
Series B - Octant Bio - 2022-04-28 - Crunchbase
Apr 28, 2022 Octant Bio raised $80000000 on 2022-04-28 in Series B. New. Resources. ... Funding Round. Series B - Octant Bio . Save . Summary. Overview. Edit Overview Section. …See details»
BIO Statement on Resignation of Peter Marks from the FDA
1 day ago John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement regarding the resignation of Peter Marks from the …See details»
Technology - octant.bio
The Octant Navigator accelerates design, build, test, learn iterations across chemistry and biology to build drugs against cellular mechanisms. Generative Biology We build mammalian synthetic …See details»